🩻 Radiology faces several challenges, including a worldwide shortage of radiologists, in the U.S., for example, the rate of imaging utilization is increasing by 6% each year, while the number of new radiologists is increasing by only 2% per year, according to the ACR - American College of Radiology. There's a rising demand for diagnostic imaging services to manage the increasing volume of radiological studies. 📉 These challenges can significantly affect the efficiency and effectiveness of radiology reporting processes, influencing #patientcare outcomes. 🌟🌟 In this context, innovative solutions are emerging to address these challenges and empower healthcare facilities to overcome these obstacles. How can Quibim's AI-powered platform enhance radiologists' capabilities? ⬇️ #PrecisionMedicine #radiology #AIInHealthcare #DigitalHealth
What do barcodes and Quibim's artificial intelligence tools have in common? Both are examples of hashtag#dataharmonization, where large data sets are standardized to make processing much simpler 🌟. At Quibim, we are transforming medical imaging data into actionable predictions. What is the benefit of #harmonizing and #standardizing all these datasets? Our CEO, Dr. Ángel Alberich-Bayarri, explains in this video how AI-driven algorithms have changed the paradigm of medical imaging ⬇️ #PrecisionMedicine #AIInHealthcare #HealthcareInnovation
📢 Save the date! Join the next webinar hosted by Xtalks 'AI and Radiomics in Drug Development: Challenges and Approaches' on Monday, January 22 at 2pm EST (11am PST). 🗣️ Featured speakers: Dr. Ronald Korn, Founder and Chief Medical Officer, Imaging Endpoints Pamod Hemakumara, Director of Corporate Development, Quibim Fuensanta Bellvís Bataller, VP of Clinical Studies, Quibim What topics will be covered? ✅The pivotal role of radiomics and AI in reshaping the future of drug development. ✅Their potential to streamline processes and usher in the era of precision medicine. ✅ Real-world applications and understanding their transformative impact on the drug development landscape. We look forward to your attendance and participation. Registration is free and open at this link: https://bit.ly/3vf9e3z
As we begin this new year, we would like to express our heartfelt thanks to our wonderful community. Thank you for being an essential part of our journey. 🥰 🌟 Over these past 12 months, we have achieved important milestones, pushed the boundaries of healthcare and collaborated with truly inspiring partners who share our dedication to a healthier future. As we enter 2024, our commitment remains steadfast: to champion ethical hashtag#AI, prioritize patient-centered technology and foster collaborations that transforms healthcare. 🎆 We wish you a splendid New Year, abundant in health, joy and numerous successes. Let us face the challenges of 2024 together and make it a year of remarkable achievements.
2023 has been an incredible journey of eye-opening events and medical breakthroughs 🌟 We can't wait to find out what 2024 has in store for us, but while we wait for the new year to begin, we wanted to take a look back at what this year has meant at Quibim. Find out everything in detail right here 👉 https://bit.ly/48fFaDR #2023WrapUp #HealthInnovation #PrecisionMedicine
In our unwavering dedication to advancing #patientcare, we are at the forefront of harnessing # the transformative power of #DeepLearning in healthcare. 🫱🏼🫲🏼 Our commitment goes beyond innovation, prioritizing patient-centered care and ensuring that every step we take is fundamentally based on the well-being and safety of each patient. But what role does #AI play in elevating patient care? Swipe to discover the advantages of these innovative solutions in clinical #healthcare. #AIinHealthare #DigitalHealth #PrecisionMedicine
At Quibim, we're excited to be at the vanguard of three groundbreaking EU projects: ProCAncer-I project, Primage Project, and The CHAIMELEON Project. Our role in advancing #AI in medical imaging is pivotal in shifting the healthcare paradigm from reactive treatment to proactive prevention and personalized medicine. Projects like ProCanAI and PRIMAGE highlight our dedication to developing AI tools that accurately interpret complex medical images, delivering crucial insights for #patientcare. In addition, our involvement in CHAIMELEON addresses significant challenges related to data availability and heterogeneity, which is crucial for advancing reproducible and explainable AI in #cancer management. 🫱🏼🫲🏼 Through these collaborations, we aim to forge sustainable AI solutions that are not just reliable and practical but also precisely meet the needs of healthcare professionals. 📋 Curious about the details of these initiatives? Discover the full story here: https://bit.ly/41CBIR6
🚀 Exciting update! The The CHAIMELEON Project Classification Phase has been extended until January 15, 2024. This gives you more time to perfect your #prostate or #lung ranking algorithms. And remember, the top 40 move on to the Championship Phase, with 100.000€ as the prize to be shared among the winners. Best of luck to all participants! 🍀
Now that the most magical time of the year is approaching, the Quibim team wishes you the happiest holidays 🌟. We hope you cherish these moments with your loved ones. Additionally, we want to express our gratitude to all #healthcare professionals for their unwavering commitment, which inspires us daily, and to all patients whose resilience and the support of their families are transforming the healthcare landscape. 👩🏻⚕️👨🏻⚕️ You represent the courage and spirit that propel healthcare forward, a true blessing to us all during this festive season. #HappyHolidays
Today we can proudly announce that QP-Brain, a tool for quantification of early brain atrophy and lesions, has received FDA 510(k) clearance, CE mark and UKCA mark. Designed to automatically quantify and display hashtag#MRI results in PACS, our GDPR and HIPAA compliant solution, which ensures hashtag#data security, identifies subtle brain alterations, helping in the early detection of diseases such as Alzheimer's, multiple sclerosis or dementia. Our regulatory-cleared medical devices are currently utilized by over 150 sites worldwide. Now available in the US, EU, and UK, QP-Brain provides secure, quantitative analysis for clinicians, transforming early diagnosis and hashtag#patientcare. Find all the details here: https://bit.ly/3S1lU7v
